BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34559985)

  • 1. Lrp1 is a host entry factor for Rift Valley fever virus.
    Ganaie SS; Schwarz MM; McMillen CM; Price DA; Feng AX; Albe JR; Wang W; Miersch S; Orvedahl A; Cole AR; Sentmanat MF; Mishra N; Boyles DA; Koenig ZT; Kujawa MR; Demers MA; Hoehl RM; Moyle AB; Wagner ND; Stubbs SH; Cardarelli L; Teyra J; McElroy A; Gross ML; Whelan SPJ; Doench J; Cui X; Brett TJ; Sidhu SS; Virgin HW; Egawa T; Leung DW; Amarasinghe GK; Hartman AL
    Cell; 2021 Sep; 184(20):5163-5178.e24. PubMed ID: 34559985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection.
    Bermúdez-Méndez E; Angelino P; van Keulen L; van de Water S; Rockx B; Pijlman GP; Ciuffi A; Kortekaas J; Wichgers Schreur PJ
    J Virol; 2023 Jun; 97(6):e0041523. PubMed ID: 37306574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice.
    Schwarz MM; Ganaie SS; Feng A; Brown G; Yangdon T; White JM; Hoehl RM; McMillen CM; Rush RE; Connors KA; Cui X; Leung DW; Egawa T; Amarasinghe GK; Hartman AL
    Sci Adv; 2023 Jul; 9(28):eadh2264. PubMed ID: 37450601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
    PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein receptor-related protein 1 (LRP1) as an auxiliary host factor for RNA viruses.
    Devignot S; Sha TW; Burkard TR; Schmerer P; Hagelkruys A; Mirazimi A; Elling U; Penninger JM; Weber F
    Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37072184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
    Cartwright HN; Barbeau DJ; McElroy AK
    mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
    Schwarz MM; Connors KA; Davoli KA; McMillen CM; Albe JR; Hoehl RM; Demers MJ; Ganaie SS; Price DA; Leung DW; Amarasinghe GK; McElroy AK; Reed DS; Hartman AL
    J Virol; 2022 Oct; 96(20):e0111222. PubMed ID: 36194021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
    Hao M; Zhang G; Zhang S; Chen Z; Chi X; Dong Y; Fan P; Liu Y; Chen Y; Song X; Liu S; Yu C; Li J; Xia X
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32120864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host entry factors of Rift Valley Fever Virus infection.
    Ganaie SS; Leung DW; Hartman AL; Amarasinghe GK
    Adv Virus Res; 2023; 117():121-136. PubMed ID: 37832991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
    Barbeau DJ; Cartwright HN; Harmon JR; Spengler JR; Spiropoulou CF; Sidney J; Sette A; McElroy AK
    J Virol; 2021 Nov; 95(23):e0150621. PubMed ID: 34495703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK
    J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
    Wichgers Schreur PJ; Oreshkova N; Moormann RJ; Kortekaas J
    J Virol; 2014 Sep; 88(18):10883-93. PubMed ID: 25008937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Host Factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.
    Phoenix I; Nishiyama S; Lokugamage N; Hill TE; Huante MB; Slack OA; Carpio VH; Freiberg AN; Ikegami T
    Viruses; 2016 May; 8(5):. PubMed ID: 27223297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice.
    Terasaki K; Kalveram B; Johnson KN; Juelich T; Smith JK; Zhang L; Freiberg AN; Makino S
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009785. PubMed ID: 34516560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.